Skip to content
On this page:OverviewPublicationsKey papers
PICO Portalanswers from OpenAlex & ORCID

C. Paul

ResearcherPublications, citations & collaboration network

C. Paul is a researcher indexed in PICO Portal from OpenAlex & ORCID.

How many works does C. Paul have?

PICO Portalindexed works

C. Paul has 849 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does C. Paul have?

PICO Portalcitation count

C. Paul has 29,140 citations in the OpenAlex counts PICO Portal stores.

What is the h-index of C. Paul?

PICO Portalh-index

C. Paul has an h-index of 92 in OpenAlex.

What is the i10-index of C. Paul?

PICO Portali10-index

C. Paul has an i10-index of 330 in OpenAlex.

What is the ORCID of C. Paul?

PICO Portalorcid

The ORCID for C. Paul is on the source record.

What is the OpenAlex record for C. Paul?

PICO Portalopenalex

The OpenAlex for C. Paul is on the source record.

What are the most-cited papers on C. Paul?

PICO Portalmost cited works
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Mark Lebwohl, Bruce Strober, Alan Menter, Kenneth B. Gordon, Jolanta Węgłowska, L. Puig, Kim Papp, Lynda Spelman, Darryl Toth, Francisco A. Kerdel, April W. Armstrong, Georg Stingl, Alexa B. Kimball, H. Bachelez, Jashin J. Wu, Jeffrey Crowley, Richard G. Langley, Tomasz Blicharski, C. Paul, J.‐P. Lacour, Stephen K. Tyring, Leon Kircik, Sergio Chimenti, Kristina Callis Duffin, Jerry Bagel, John Koo, Gary Aras, Joanne Li, Wenjie Song, Cassandra E. Milmont, Yifei Shi, Ngozi Erondu, Paul Klekotka, Brian L. Kotzin, Ajay Nirula
New England Journal of Medicine. 2015812 CitationsOPEN ACCESS
Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey
Mark Lebwohl, H. Bachelez, Jonathan Barker, Giampiero Girolomoni, Arthur Kavanaugh, Richard G. Langley, C. Paul, L. Puig, Kristian Reich, P.C.M. van de Kerkhof
Journal of the American Academy of Dermatology. 2014515 Citations
Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)
C. Paul, Jennifer Clay Cather, Melinda Gooderham, Yves Poulin, Ulrich Mrowietz, C. Ferrandiz, J. Crowley, ChiaChi Hu, R.M. Stevens, Kara N. Shah, R. M. Day, Giampiero Girolomoni, A.B. Gottlieb
British Journal of Dermatology. 2015480 CitationsOPEN ACCESS
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
Andreas Wollenberg, Stéphanie Christen-Zäch, Alain Taı̈eb, C. Paul, Jacob P. Thyssen, Marjolein de Bruin‐Weller, Christian Vestergaard, Julien Sénéschal, Thomas Werfel, Michael J. Cork, B Kunz, Regina Fölster‐Holst, Magdalena Trzeciak, Ulf Darsow, Zsuzsanna Szalai, Mette Deleuran, Laura von Kobyletzki, S. Barbarot, Annice Heratizadeh, Uwe Gieler, DirkJan Hijnen, Stephan Weidinger, L. De Raeve, Åke Svensson, Dagmar Simon, J.‐F. Stalder, Johannes Ring, for the European Task Force on Atopic Dermatitis/EADV Eczema Task Force
Journal of the European Academy of Dermatology and Venereology. 2020472 CitationsOPEN ACCESS
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg, Diamant Thaçi, C. Paul, Andrew Pink, Yoko Kataoka, Chia‐Yu Chu, Marco DiBonaventura, Ricardo Rojo, Jeremias Antinew, Ileana A. Ionita, Rodney Sinclair, Seth Forman, Jacek Zdybski, Pinaki Biswas, Bimal Malhotra, Fan Zhang, Hernán Valdez
New England Journal of Medicine. 2021462 CitationsOPEN ACCESS

Related on PICO Portal

470M+ articles · 14-day free trial